|
Volumn 91, Issue 6, 2005, Pages 1488-1490
|
Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUPRENORPHINE;
DRINKING WATER;
OPIATE;
SULFADIAZINE;
PARASITOLOGY;
ANALGESIA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CLINICAL OBSERVATION;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DRUG POTENCY;
FEMALE;
MOUSE;
NONHUMAN;
PAIN ASSESSMENT;
STRAIN IDENTIFICATION;
SURVIVAL;
TOXOPLASMA GONDII;
TOXOPLASMOSIS;
TREATMENT INDICATION;
ACUTE DISEASE;
ANALGESICS, OPIOID;
ANIMALS;
BUPRENORPHINE;
CELL LINE;
CERCOPITHECUS AETHIOPS;
COCCIDIOSTATS;
DISEASE MODELS, ANIMAL;
FEMALE;
MICE;
PAIN;
SULFADIAZINE;
TOXOPLASMA;
TOXOPLASMOSIS, ANIMAL;
ANIMALIA;
MURINAE;
TOXOPLASMA GONDII;
|
EID: 32544451625
PISSN: 00223395
EISSN: None
Source Type: Journal
DOI: 10.1645/GE-732R.1 Document Type: Article |
Times cited : (7)
|
References (5)
|